CareDx, Inc. (NASDAQ: CDNA) Stock Information | RedChip

CareDx, Inc. (NASDAQ: CDNA)


$22.7950
-2.2700 ( -9.90% ) 621.5K
At close: Jan 14, 2025, 4:00 PM EDT.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Market Data


Open


$22.7950

Previous close


$25.0700

Volume


621.5K

Market cap


$1.33B

Day range


$22.6700 - $25.8640

52 week range


$7.4200 - $34.8400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 10, 2024
4 Insider transactions 1 Jul 08, 2024
4/a Other 1 Jun 24, 2024
4 Insider transactions 1 Jun 20, 2024
4/a Other 1 Jun 20, 2024
4/a Other 1 Jun 20, 2024
4/a Other 1 Jun 20, 2024
4/a Other 1 Jun 20, 2024

Latest News